Annual Working Capital
$60.57 M
-$15.99 M-20.88%
December 31, 2024
Summary
- As of March 8, 2025, JSPR annual working capital is $60.57 million, with the most recent change of -$15.99 million (-20.88%) on December 31, 2024.
- During the last 3 years, JSPR annual working capital has fallen by -$19.24 million (-24.10%).
- JSPR annual working capital is now -24.10% below its all-time high of $79.81 million, reached on December 31, 2021.
Performance
JSPR Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Working Capital
$60.57 M
-$21.77 M-26.44%
December 31, 2024
Summary
- As of March 8, 2025, JSPR quarterly working capital is $60.57 million, with the most recent change of -$21.77 million (-26.44%) on December 31, 2024.
- Over the past year, JSPR quarterly working capital has dropped by -$21.77 million (-26.44%).
- JSPR quarterly working capital is now -51.39% below its all-time high of $124.62 million, reached on March 31, 2023.
Performance
JSPR Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Working Capital Formula
Working Capital = Current Assets − Current Liabilities
JSPR Working Capital Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -20.9% | -26.4% |
| 3 y3 years | -24.1% | -35.1% |
| 5 y5 years | +263.3% | -35.1% |
JSPR Working Capital Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -24.1% | +74.7% | -51.4% | +74.7% |
| 5 y | 5-year | -24.1% | +263.3% | -51.4% | +263.3% |
| alltime | all time | -24.1% | +263.3% | -51.4% | +263.3% |
Jasper Therapeutics Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $60.57 M(-20.9%) | $60.57 M(-26.4%) |
| Sep 2024 | - | $82.35 M(-16.5%) |
| Jun 2024 | - | $98.61 M(-11.5%) |
| Mar 2024 | - | $111.39 M(+45.5%) |
| Dec 2023 | $76.56 M | $76.56 M(-17.9%) |
| Sep 2023 | - | $93.31 M(-14.9%) |
| Jun 2023 | - | $109.59 M(-12.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2023 | - | $124.62 M(+259.5%) |
| Dec 2022 | $34.67 M(-56.6%) | $34.67 M(-22.9%) |
| Sep 2022 | - | $44.99 M(-20.6%) |
| Jun 2022 | - | $56.66 M(-16.5%) |
| Mar 2022 | - | $67.83 M(-15.0%) |
| Dec 2021 | $79.81 M(+378.7%) | $79.81 M(-14.4%) |
| Sep 2021 | - | $93.25 M(+459.3%) |
| Dec 2020 | $16.67 M | $16.67 M |
FAQ
- What is Jasper Therapeutics annual working capital?
- What is the all time high annual working capital for Jasper Therapeutics?
- What is Jasper Therapeutics annual working capital year-on-year change?
- What is Jasper Therapeutics quarterly working capital?
- What is the all time high quarterly working capital for Jasper Therapeutics?
- What is Jasper Therapeutics quarterly working capital year-on-year change?
What is Jasper Therapeutics annual working capital?
The current annual working capital of JSPR is $60.57 M
What is the all time high annual working capital for Jasper Therapeutics?
Jasper Therapeutics all-time high annual working capital is $79.81 M
What is Jasper Therapeutics annual working capital year-on-year change?
Over the past year, JSPR annual working capital has changed by -$15.99 M (-20.88%)
What is Jasper Therapeutics quarterly working capital?
The current quarterly working capital of JSPR is $60.57 M
What is the all time high quarterly working capital for Jasper Therapeutics?
Jasper Therapeutics all-time high quarterly working capital is $124.62 M
What is Jasper Therapeutics quarterly working capital year-on-year change?
Over the past year, JSPR quarterly working capital has changed by -$21.77 M (-26.44%)